Skip to the page

Data / Form D filings / Neograft Technologies, Inc.

Neograft Technologies, Inc.: Form D filings

Neograft Technologies, Inc., a health care company in Taunton, MA, filed 6 Form D notices with the SEC between 2010 and 2017. The latest, on January 26, 2017, reports $5 million sold of a $5 million offering to 3 investors.

Find out what Neograft Technologies, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
470 Constitution Dr., Taunton, MA, 02780
Phone
(508) 802-4122
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1481953

The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 26, 2017New notice$5,000,000$5,000,000$03Jan 16, 2017sec.gov
Jul 14, 2014New notice$11,000,000$11,000,000$06Jul 3, 2014sec.gov
Aug 30, 2013New notice$3,999,994$3,999,994$05Aug 26, 2013sec.gov
Aug 11, 2011AmendmentIndefinite$8,000,000Indefinite7Dec 8, 2010sec.gov
Dec 21, 2010New noticeIndefinite$3,000,000Indefinite5Dec 8, 2010sec.gov
Jan 25, 2010New notice$7,700,000$6,300,000$1,400,0003Jan 4, 2010sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jon McGrathExecutive Officer, Director
Richard C. Petersen, Jr.Director
Michael Richard TovianDirector
Christopher C. PetersenDirector
Thomas Richard DuganDirector
Brad Richard PetersenDirector

Other health care companies in Massachusetts that filed recently

Every Form D from the week of Jan 23, 2017 · All recent filings in Massachusetts · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Neograft Technologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.